Physitracks Q4 results aligned with its preliminary figures, highlighted by continued margin expansion and improved free cash flow (FCF) for FY 2025, reflecting the focus on operational efficiency. Yet, sales growth stalled during the quarter; while this remains our primary concern within the reported figures, it was also consistent with our existing forecasts. Given the close alignment with forecasts and postetive outlook from management, only minor estimate revisions are expected.
LÄS MER
